Jeffrey L. Cleland,George M. Bright,Eric Humphriss,Volker Schellenberger,Joshua Silverman,Willem P. Stemmer,Chia-Wei Wang,Nathan Greething,Benjamin Spink
申请号：
US15648967
公开号：
US20180051063A1
申请日:
2017.07.13
申请国别(地区):
US
年份:
2018
代理人:
摘要：
The present invention concerns an improved therapeutic regimen for GHD therapy. In particular, the invention concerns methods for bolus dose administration of a human growth hormone-XTEN (hGH-XTEN) fusion protein.
